The medicine
"Tamiflu" the instructions for use are as an
antiviral agent that is part of the pro-drug group. This drug is based on the competitive and selective inhibition of neuraminidase of pathogenic influenza A and B microorganisms. This process occurs due to the catalyzed release of the virus from infected cells and the obstacle to its penetration into the epithelial cells of the respiratory system. As a result of using Tamiflu (the instructions for use must be attached), the further spread of bacteria in the body is blocked. When taking this drug for the purpose of prevention, the risk of influenza in contacted persons is significantly reduced, and the transmission of infection from one family member to another is also prevented. You can buy this antiviral medicine today in almost every pharmacy, the cost of Tamiflu is about 1000-1100 rubles.

This drug is available in the form of gelatin capsules and in the form of a powder intended for the preparation of a suspension for further oral administration. As an active ingredient, oseltamivir is part of the drug. Capsules contain it in a volume of 75 mg, and powder in a volume of 30 mg. The dragee also additionally includes such substances as: povidone K30, talc, pregelatinized starch, sodium fumarate stearyl and croscarmellose sodium. The powder contains sorbitol, xanthan gum, permutil Tutti-Frutti and titanium dioxide as auxiliary ingredients. In addition, it contains a small amount of monosodium citrate,
sodium benzoate and sodium saccharin.
Take the drug "Tamiflu" instructions for use recommends for the treatment of influenza in both adults and children over one year old. In addition, this medicine is actively prescribed for the prevention of viral infections in patients of different age categories. Quite often, this drug is used to prevent influenza in people working in large production teams, in military units or simply with weakened immunity.
It is strictly forbidden to take this antiviral medicine in case of individual intolerance to oseltamivir or an allergic reaction to any of its other components. People suffering from chronic renal failure should also refrain from taking Tamiflu capsules. An antiviral drug should not be taken while bearing a child. Women who are breastfeeding should also give up this medication.
As for adverse reactions, as a rule, patients complain of vomiting and nausea in the first few days of taking the drug. In addition, abdominal pain, diarrhea, dizziness, weakness, coughing and bronchitis due to the use of Tamiflu may be observed. Instructions for use indicate the risk of sleep disturbances, the development of dyspepsia and rhinorrhea.